Co-Diagnostics, Inc.
Co-Diagnostics, Inc.（CODX）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · CODX · 截至 2025年3月31日
股东结构概览
39
机构持有人数
▼ 4 vs Q4
$1.81M
机构持仓总市值
▼ $2.48M vs Q4
1.12M
总流通股
freeFloat 93.27%
5.84M
13F 申报持股数
▲ 120,287 vs Q4
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
CODX 最大股东 · 机构持仓
Q1 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC surgical & medical instruments & apparatus | 1.78M | 5.55% | 5.55% | $551.24M | May 9, 2025 | — held |
PRIVATE ADVISORY GROUP LLC surgical & medical instruments & apparatus | 1.18M | 3.69% | 3.69% | $365.83M | May 8, 2025 | — held |
RENAISSANCE TECHNOLOGIES LLC surgical & medical instruments & apparatus | 550.3K | 1.72% | 1.72% | $170.38M | May 14, 2025 | ▼ 5.3K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 502.8K | 1.57% | 1.57% | $155.66M | May 2, 2025 | ▼ 1.4K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 342.2K | 1.07% | 1.07% | $105.97M | May 13, 2025 | ▼ 3.3K |
BRIDGEWAY CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 272.9K | 85.15% | 85.15% | $84.49M | May 15, 2025 | — held |
SUSQUEHANNA INTERNATIONAL GROUP, LLP surgical & medical instruments & apparatus | 213.3K | 66.56% | 66.56% | $66.04M | May 14, 2025 | ▼ 45.8K |
CITADEL ADVISORS LLC surgical & medical instruments & apparatus | 189.1K | 59.01% | 59.01% | $58.55M | May 15, 2025 | ▲ 172.7K |
BANK OF NEW YORK MELLON CORP surgical & medical instruments & apparatus | 137.1K | 42.77% | 42.77% | $42.44M | Apr 29, 2025 | — held |
KESTRA ADVISORY SERVICES, LLC surgical & medical instruments & apparatus | 124.5K | 38.86% | 38.86% | $38.55M | May 14, 2025 | ▲ 1.7K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q1 2025 对比上季度
Q1 2025
10
增持
+309.1K 股6
新建仓
首次建仓10
减持
−129.2K 股8
清仓
完全退出净股数变化（前50家）
+180.0K
+309.1K / −129.2K
净新增持仓人
-2
新建 6 个 / 退出 8 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
CODX 内幕交易记录
数据来源：SEC Form 4
7
买入笔数
10
卖出笔数
0.70
买卖比
$1M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Egan Dwight H Chief Executive Officer | May 23, 2026 | Award | 4,584 | — | — | 29.5K | Form 4 ↗ |
Egan Dwight H Chief Executive Officer | May 23, 2026 | D-Return | 1,633 | $5.07 | $8.3K | 27.9K | Form 4 ↗ |
Brown Brian Lee Chief Financial Officer | May 23, 2026 | Award | 3,750 | — | — | 23.7K | Form 4 ↗ |
Brown Brian Lee Chief Financial Officer | May 23, 2026 | D-Return | 1,350 | $5.07 | $6.8K | 22.4K | Form 4 ↗ |
Abbott Richard David President | May 23, 2026 | Award | 1,890 | — | — | 4.1K | Form 4 ↗ |
Abbott Richard David President | May 23, 2026 | D-Return | 680 | $5.07 | $3.4K | 3.4K | Form 4 ↗ |
Murphy Edward L. director | May 23, 2026 | Award | 1,695 | — | — | 11.1K | Form 4 ↗ |
SERBIN RICHARD S director | May 23, 2026 | Award | 1,695 | — | — | 10.8K | Form 4 ↗ |
Durenard Eugene director | May 23, 2026 | Award | 1,695 | — | — | 10.7K | Form 4 ↗ |
NELSON JAMES B director | May 23, 2026 | Award | 1,695 | — | — | 10.7K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Co-Diagnostics, Inc.（CODX）主要由机构投资者持有，机构持股比例约为 100.0%。公司内部人员持股约 6.73%，散户及公众持股约占剩余的 0.00%。
Co-Diagnostics, Inc. 最大机构股东为 VANGUARD GROUP INC，截至 March 31, 2025 持有约 1.78 million 股，占总流通股的 5.55%。
目前共有 39 家机构持有 CODX 股票，合计持仓市值约 $1,809,752，数据来源为最新 SEC 13F 申报。
常见问题
CODX ownershipCo-Diagnostics, Inc.（CODX）主要由机构投资者持有，机构持股约 100.0%。最大股东为 VANGUARD GROUP INC，持股比例 5.55%。内部人员持股约 6.73%。数据来源 SEC Form 13F，截至 March 31, 2025。